MONOPAR
THERAPEUTICS INC.
CONFIRMING
STATEMENT
REGARDING
AUTHORITY TO EXECUTE SECTION 16(a) REPORTS
This
Statement confirms that the undersigned, Jose Octavio Pinto Costa
Filho c/o Monopar Therapeutics Inc., 1000 Skokie Blvd., Suite 350,
Wilmette, IL 60091 (the “Insider”), has authorized and
designated Kim R. Tsuchimoto and Chandler D. Robinson of Monopar
Therapeutics Inc. (the “Company”), John Harrington and
Robert Rupp, Esq. of Baker Hostetler, the Company’s United
States legal counsel, and each of them (each of the foregoing is
referred to as an “Authorized Signer”) to execute and
file on the Insider’s behalf a Form ID and any and all Forms
3, 4 and 5 (including any amendments thereto) that the Insider may
be required to file with the United States Securities and Exchange
Commission under Section 16(a) of the Securities Exchange Act of
1934, as a result of the Insider’s ownership of, or
transactions in, securities of the Company. The authority of the
Authorized Signers under this Confirming Statement shall continue
until the Insider is no longer required to file Forms 3, 4 and 5
with regard to the Insider’s ownership of, or transactions
in, securities of the Company, unless earlier revoked in writing.
The Insider acknowledges that none of the Authorized Signers is
assuming any of the Insider’s responsibilities to comply with
Section 16 of the Securities Exchange Act of 1934.
/s/ Jose Octavio Pinto
Costa Filho
Jose Octavio Pinto Costa Filho